Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 2c; Raises FY
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $18.63 --0%
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $119.2 million.
Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Teck Resources (TECK) Misses Q1 EPS by 15c; reaffirms FY guidance
- Lam Research (LRCX) PT Raised to $1,025 at Citi, 'Buy This Pullback'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
